Go Pro
NASDAQ:PETS

PetMed Express Q4 2025 Earnings Report

PetMed Express logo
$1.53 0.00 (0.00%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$1.55 +0.02 (+1.31%)
As of 09/25/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PetMed Express EPS Results

Actual EPS
-$0.56
Consensus EPS
$0.04
Beat/Miss
Missed by -$0.60
One Year Ago EPS
N/A

PetMed Express Revenue Results

Actual Revenue
$46.47 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PetMed Express Announcement Details

Quarter
Q4 2025
Time
Before Market Opens
Conference Call Date
Tuesday, October 14, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

PetMed Express' Q2 2027 earnings is estimated for Tuesday, October 13, 2026, based on past reporting schedules

PetMed Express Earnings Headlines

PetMeds Appoints Tamar Elkeles As Independent Director
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live.tc pixel
PetMed Express adds human capital expert to board
See More PetMed Express Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PetMed Express? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetMed Express and other key companies, straight to your email.

About PetMed Express

PetMed Express (NASDAQ:PETS), doing business as PetMeds, is a direct-to-consumer pet pharmacy and online retailer. The company sells prescription and nonprescription medications, flea and tick treatments, vitamins and supplements, prescription diets, and other health products for dogs, cats, and other companion animals.

PetMeds offers products through its website and other direct-order channels, providing pet owners with access to medications and supplies that may be recommended or prescribed by veterinarians. Its business model is focused on convenience, home delivery, and recurring purchases for ongoing pet-health needs.

Founded in 1996, PetMed Express is headquartered in Delray Beach, Florida, and primarily serves customers in the United States. The company operates under the PetMeds and 1-800-PetMeds brands and is traded on the Nasdaq under the symbol PETS.

View PetMed Express Profile